Original Article

Substrate specificity of the ileal and the hepatic Na⁺/bile acid cotransporters of the rabbit. II. A reliable 3D QSAR pharmacophore model for the ileal Na⁺/bile acid cotransporter

Correspondence to: Werner Kramer

To design a reliable 3D QSAR model of the intestinal Na⁺/bile acid cotransporter, we have used a training set of 17 inhibitors of the rabbit ileal Na⁺/bile acid cotransporter. The IC₅₀ values of the training set of compounds covered a range of four orders of magnitude for inhibition of [³H]cholyltaurine uptake by CHO cells expressing the rabbit ileal Na⁺/bile acid cotransporter allowing the generation of a pharmacophore using the CATALYST algorithm. After thorough conformational analysis of each molecule, CATALYST generated a pharmacophore model characterized by five chemical features: one hydrogen bond donor, one hydrogen bond acceptor, and three hydrophobic features. The 3D pharmacophore was enantiospecific and correctly estimated the activities of the members of the training set. The predicted interactions of natural bile acids with the pharmacophore model of the ileal Na⁺/bile acid cotransporter explain exactly the experimentally found structure;–activity relationships for the interaction of bile acids with the ileal Na⁺/bile acid cotransporter (Kramer et al. 1999. J. Lipid. Res. 40: 1604;–1617).

The natural bile acid analogues cholyltaurine, chenodeoxycholyltaurine, or deoxycholyltaurine were able to map four of the five features of the pharmacophore model: a) the five-membered ring D and the methyl group at position 18 map one hydrophobic site and the 21-methyl group of the side chain maps a second hydrophobic site; b) one of the -oriented hydroxyl groups at position 7 or 12 fits the hydrogen bond donor feature; c) the negatively charged side chain acts as hydrogen bond acceptor; and d) the hydroxy group at position 3 does not specifically map any of the five binding features of the pharmacophore model. The 3-hydroxy group of natural bile acids is not essential for interactions with ileal or hepatic Na⁺/bile acid cotransporters. A modification of the 3-position of a natural bile acid molecule is therefore the preferred position for drug targeting strategies using bile acid transport pathways.—Baringhaus, K-H., H. Matter, S. Stengelin, and W. Kramer. Substrate specificity of the ileal and the hepatic Na⁺/bile acid cotransporters of the rabbit. II. A reliable 3D QSAR pharmacophore model for the ileal Na⁺/bile acid cotransporter. J. Lipid Res. 1999. 40: 2158;–2168.

Supplementary key words: bile acids, 3D QSAR, pharmacophore model, structure;–activity relationships, ileum, liver

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				N. Hussainzada, T. C. Da Silva, E. Y. Zhang, and P. W. Swaan Conserved Aspartic Acid Residues Lining the Extracellular Loop I of Sodium-coupled Bile Acid Transporter ASBT Interact with Na+ and 7{alpha}-OH Moieties on the Ligand Cholestane Skeleton J. Biol. Chem., July 25, 2008; 283(30): 20653 - 20663. [Abstract] [Full Text] [PDF]

				J. Geyer, B. Doring, K. Meerkamp, B. Ugele, N. Bakhiya, C. F. Fernandes, J. R. Godoy, H. Glatt, and E. Petzinger Cloning and Functional Characterization of Human Sodium-dependent Organic Anion Transporter (SLC10A6) J. Biol. Chem., July 6, 2007; 282(27): 19728 - 19741. [Abstract] [Full Text] [PDF]

				A.-Q. Sun, N. Balasubramaniyan, H. Chen, M. Shahid, and F. J. Suchy Identification of Functionally Relevant Residues of the Rat Ileal Apical Sodium-dependent Bile Acid Cotransporter J. Biol. Chem., June 16, 2006; 281(24): 16410 - 16418. [Abstract] [Full Text] [PDF]

				S. Hata, P. Wang, N. Eftychiou, M. Ananthanarayanan, A. Batta, G. Salen, K. S. Pang, and A. W. Wolkoff Substrate specificities of rat oatp1 and ntcp: implications for hepatic organic anion uptake Am J Physiol Gastrointest Liver Physiol, November 1, 2003; 285(5): G829 - G839. [Abstract] [Full Text] [PDF]

				O. Briz, M. A. Serrano, N. Rebollo, B. Hagenbuch, P. J. Meier, H. Koepsell, and J. J.G. Marin Carriers Involved in Targeting the Cytostatic Bile Acid-Cisplatin Derivatives cis-Diammine-chloro-cholylglycinate-platinum(II) and cis-Diammine-bisursodeoxycholate-platinum(II) toward Liver Cells Mol. Pharmacol., April 1, 2002; 61(4): 853 - 860. [Abstract] [Full Text] [PDF]

				D. Schwab, A. W. Herling, H. Hemmerle, G. Schubert, B. Hagenbuch, and H.-J. Burger Hepatic Uptake of Synthetic Chlorogenic Acid Derivatives by the Organic Anion Transport Proteins J. Pharmacol. Exp. Ther., January 1, 2001; 296(1): 91 - 98. [Abstract] [Full Text]

				W. Kramer, K. Sauber, K.-H. Baringhaus, M. Kurz, S. Stengelin, G. Lange, D. Corsiero, F. Girbig, W. Konig, and C. Weyland Identification of the Bile Acid-binding Site of the Ileal Lipid-binding Protein by Photoaffinity Labeling, Matrix-assisted Laser Desorption Ionization-Mass Spectrometry, and NMR Structure J. Biol. Chem., March 2, 2001; 276(10): 7291 - 7301. [Abstract] [Full Text] [PDF]

				W. Kramer, F. Girbig, H. Glombik, D. Corsiero, S. Stengelin, and C. Weyland Identification of a Ligand-binding Site in the Na+/Bile Acid Cotransporting Protein from Rabbit Ileum J. Biol. Chem., September 14, 2001; 276(38): 36020 - 36027. [Abstract] [Full Text] [PDF]